Navigation

2006/034 New NICE guidance to help sufferers of psoriasis and psoriatic arthritis

The National Institute for Health and Care Excellence (NICE) has today (Wednesday 26 July) launched guidance on the use within the NHS in England and Wales of etanercept and efalizumab for the treatment of psoriasis, and etanercept and infliximab for the treatment of psoriatic arthritis (PsA).

Further information

This page was last updated: 03 July 2009

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.